Polyurethanes offer the greatest versatility in compositions and properties of any family of polymers. For implantable medical devices, a few specific elastomeric polyurethane compositions have demonstrated a combination of toughness, durability, biocompatibility and biostability not achieved by any other available material.
Because of the complex behavior of implantable polyurethanes in the body environment, designers and fabricators of polyurethane-containing devices must pay particular attention to the choice of composition and design of components. Subsequent treatment during qualification, fabrication, sterilization, storage, implantation, in vivo operation and explantation also determine the performance and provide the means for assessing the efficacy of the polyurethane in the implanted device.
Get full access to this article
View all access options for this article.
References
1.
Frisch, K. and J. Saunders.Polyurethanes: Chemistry and Technology. Part I, Chemistry, Part II, Technology. New York: Interscience Publishers (1962, 1964).
2.
Lelah, M. and S. Cooper.Polyurethanes in Medicine. Boca Raton, FL:CRC Press, Inc. (1986).
3.
Coury, A., K. Cobian, P. Cahalan and A. Jevne. "Biomedical Uses of Polyurethanes" Advances in Urethane Science and Technology, Vol. 9. pp. 130-168 (1984).
4.
Coury, A., P. Slaikeu, P. Cahalan and K. Stokes. "Medical Applications of Implantable Polyurethanes: Current Issues;' Proceedings, The Plastics and Rubber Institute International Symposium, "Polyurethanes '87" (October 14, 1987 , London, England (1987).
5.
Dow Corning Corporation, Product Literature, Forms No. 51-209A (May, 1979) and 51-582A-83.
6.
Ashar, B. and L. Turcotte. "Analyses of Longest IAB Implant in Human Patient (317 Days)," Trans. Am. Soc. Artif. Intern. Organs, XXVII:372-379 (1981).
7.
Olson, D. "ISAO International Registry," Artificial Organs, New York: Raven Press, 11(1):63-68 (1986).
8.
Stokes, K. and T. Church. 'Ten.Year Experience with Implanted Polyurethane Lead Insulation ," PACE, Vol. 9, Part II, pp. 1160-1165 (Nov.-Dec., 1986).
9.
Dow Chemical U.S.A., Product Literature Forms No. 306-051 to -070 and -486.
10.
Phillips, W., W. Pierce, et al. "The Use of Segmented Polyurethane in Ventricular Assist Devices and Artificial Hearts," in Synthetic Biomedical Polymers: Concepts and Applications. M. Szycher and W. Robinson, eds. Lancaster, PA: Technomic Publishing Co., Inc., pp. 39-57 (1980).
11.
Thermo Electron Biomedical Systems Product Literature, "Tecoflex:'
Fabris, H. "Thermal and Oxidative Stability of Urethanes," in Advances in Urethane Science and Technology, Vol. 4. K. Frisch and S. Reegen, eds. Lancaster, PA: Technomic Publishing Co., Inc., pp. 105-106 (1976).
14.
Ulrich, H. and H. Bonk. "Emerging Biomedical Applications of Polyurethane Elastomers ," Proceedings of the SPI 27th Annual Technical/Market. ing Conference, Bal Harbor, FL, p. 147 (1982).
15.
Poirier, V. "Fabrication and Testing of Flocked Blood Pump Bladders;' Synthetic Biomedical Polymers: Concepts and Applications. M. Szycher and W. Robinson, eds. Lancaster, PA:Technomic Publishing Co., Inc., p. 83 (1980).
16.
Mathur, G., J. Kresta and K. Frisch. "Stabilization of Polyetherurethanes and Polyether (Urethane-Urea) Block Copolymers," in Advances in Urethane Science and Technology , Vol. 6. K. Frisch and S. Reegen, eds. Lancaster, PA:Technomic Publishing Co., Inc., pp. 103-172 (1978).
17.
Ibid, pp. 122-126.
18.
Coury, A., P. Cahalan, P. Slaikeu and K. Stokes. "In Vitro Chemical Resistance of Implantable Polyurethanes ," Transactions of the 11 th Annual Meeting of the Society for Biomaterials, April 25-28, 1985, San Diego, CA, p. 7 (1985).
19.
Dow Chemical USA Product Literature, "Regulatory Information, 2363 Series, Pellethane Polyurethane Elastomers," Form No. 306-078-486.
20.
Ratner, B. "Pblyetherurethane Surfaces: Chemical and Morphological Exchanges Upon Extraction," Transactions, Polymer IUPAC Symposium , Amherst, MA, p. 677 (1982).
21.
Hanson, S., L. Harker, et al. "In Vivo Evaluation of Artificial Surfaces with a Nonhuman Primate Model of Arterial Thrombosis," Jour. Lab. Clin. Med., 95:289-304 (Feb., 1980).
22.
Szycher, M."Extrudable Polyurethane for Prosthetic Devices Prepared from a Diisocyanate, a Polytetramethylene Ether Polyol and 1,4-Butanediol," U.S. Patent #4,447,590 to Thermo Electron Corporation (May 8, 1984).
23.
Graham, S. and D. Hercules. "Surface Spectroscopic Studies of Biomer," Jour. Biomed. Mater. Res., 15:465-477 (1981).
24.
Graham, S. and D. Hercules. "Surface Spectroscopic Studies of Avcothane," Jour. Biomed. Mater. Res., 15:349-361 (1981).
25.
Woodcock, J. "Microporous Polyurethanes and Their Applications," Proceedings, the Plastics and Rubber Institute International Symposium: "Polyurethanes '87," October 14, 1987, London , England, p. 5 (1987).
26.
Stokes, K., A. Coury and P. Urbanski. "Autooxidative Degradation of Implanted Polyether Polyurethane Devices," Journal of Biomaterials Applications, 1(4):407-448 (April, 1987).
27.
Frisch, K. and J. Saunders.Polyurethanes: Chemistry and Technology, Part I, Chemistry . New York, NY:Interscience Publishers , p. 330 ( 1962).
28.
Dow Chemical USA, Pellethane 2363 Series Product Literature, Forms No. 306-053-486, 306-061-486, 306-066-486, 306-057-486, 306-063-486 and 306-068-486.
29.
Cooper, S. and A. Tobolsky. "Properties of Linear Elastomeric Polyurethanes," J. Appl . Polymer Sci., 10:1837-1844 (1966 ).
30.
Lelah, chapter 4, pp. 35-55.
31.
Bonart, R."X-Ray Investigations Concerning the Physical Structure of Crosslinking in Segmented Urethane Elastomers," J. Macromol. Sci. Phys., B7:115-138 (1968).
32.
Cooper, S., J. West and R. Seymour."Polyurethane Block Copolymers," Encyclopedia of Polymer Science and Technology, Vol. 1. N. Bikales, ed. New York:John Wiley & Sons, pp. 528-530 (1976).
33.
Schollenberger, C. and K. Dinbergs. "Thermoplastic Urethane Chemical Crosslinking Effects," in Advances in Urethane Science and Technology, Vol. 6. K. Frisch and S. Reegen, eds. Lancaster, PA: Technomic Publishing Co., Inc., pp. 60-78 (1978).
34.
Morbitzer, L. and H. Hespe. "Correlation Between Chemical Structure, Stress Induced Crystallization and Deformation Behavior of Polyurethane Elastomers ," Jour. Appl. Pol. Sci., 16:2697-2708 (1972).
35.
Communication from Dr. S. W. Wong, University of Detroit.
36.
Lilaonitkul, A. and S. Cooper. "Properties of Thermoplastic Polyurethane Elastomers," in Advances in Urethane Science and Technology , Vol. 7. K. Frisch and S. Reegen, eds. Lancaster, PA:Technomic Publishing Co., Inc., pp. 163-183 (1979).
37.
Frisch, K. "Recent Advances in the Chemistry of Urethanes," in Advances in Urethane Science and Technology, Vol. 2. K. Frisch and S. Reegen, eds. Lancaster, PA: Thechnomic Publishing Co., Inc., p. 10 (1973).
38.
Frisch, K., S. Reegen and L. Rumao. "Effect of Isocyanate Structure on Physical Properties and Degradation of One Component Urethane Coatings," in Advances in Urethane Science and Technology, Vol. 1. K. Frisch and S. Reegen, eds. Lancaster, PA:Technomic Publishing Co., Inc., pp. 49-63 (1971).
39.
Ward, R. "Comparison of Aromatic and Aliphatic Polyetherurethanes for Biomedical Use II, Results of Accelerated Biaxial Flex Testing at 37°C," Transactions, 11th Annual Meeting of the Society for Biomaterials , April 25-28, 1985, San Diego, CA, p. 57 (1985).
40.
Schollenberger, C. and D. Stewart. "Thermoplastic Urethane Structure and Ultraviolet Stability," in Advances in Urethane Science and Technology, Vol. 2. K. Frisch and S. Reegen, eds. Lancaster, PA:Technomic Publishing Co., Inc., pp. 71-108 (1973).
41.
Matuzak, M. , K. Frisch and S. Reegen. "Hydrolysis of Linear Polyurethanes and Model Monocarbamates," J. Pol. Sci., Pol. Chem., Ed., 11: 1683-1690 (1973).
42.
Lelah, chapter 16, pp. 205-207.
43.
Mazzu, A. and C. Smith. "Determination of Extractable Methylene Dianiline in Thermoplastic Polyurethanes by HPLC," Jour. Biomed Mater. Res., 18:961-968 (1984).
44.
Lyman, D. "Structural Order and Blood Compatibility of Polymeric Prostheses," in Structural Order in Chemistry. F. Ciardelli, ed. Oxford, NY: Pergamon Press, pp. 205-220 (1981).
45.
Szycher, M. and V. Poirier. "High Performance Tecoflex Polyurethanes in Biomedical Applications," in Advances in Biomaterials, Vol. 1. S. Lee, ed. Lancaster, PA:Technomic Publishing Co., Inc., pp. 110-118 (1987).
46.
Lelah, chapter 5, p. 57.
47.
Personal communication from Dr. M. Szycher, Thermedics, Inc.
48.
Klempner, D., K. Frisch and C. Wang. "Structure-Property Relationships and Morphology of Isocyanurate-Containing Urethane Elastomers," in Advances in Urethane Science and Technology , Vol. 9. K. Frisch and D. Klempner, eds. Lancaster, PA:Technomic Publishing Co., Inc., pp. 102-129 (1984).
49.
Mendelsohn, M., F. Navish, Jr. and D. Kim. "Effects of Chemical Composition on Viscoelastic-Mechanical Properties of Cast Elastomeric Polyurethanes," in Advances in Urethane Science and Technology, Vol. 10. K. Frisch and D. Klempner , eds. Lancaster, PA:Technomic Publishing Co., Inc., pp. 30-31 (1987).
50.
Lelah, chapter 4, p. 53.
51.
Stokes, K., A. Frazer and E. Carter. "The Biostability of Various Polyether Polyurethanes Under Stress," in Advances In Biomaterials. S. Lee, ed. Lancaster, PA:Technomic Publishing Co., Inc., pp. 235-244 (1987).
Frisch, K. and J. Saunders.Polyurethane: Chemistry and Technology, Part I, Chemistry . New York:Interscience Publishers , p. 329 ( 1962).
55.
Coury, A., K. Cobian, P. Cahalan and A. Jevne. "Biomedical Uses of Polyurethanes," in Advances in Urethane Science and Technology, Vol. 9. K. Frisch and D. Klempner, eds. Lancaster, PA: Technomic Publishing Co., Inc., pp. 133-139 (1984).
56.
Autian, J. "Biological Models for the Testing of the Toxicity of Biomaterials ," in Polymers in Medicine and Surgery. R. Kronenthal et al., eds. New York: Plenum Press, pp. 181-203 (1974).
57.
Lelah, chapters 8-12, pp. 111-169.
58.
Lelah, chapter 7, pp. 85-109.
59.
Isayev, I. and D. Crouthamel. "Residual Stress Development in the Injection Molding of Polymers," Fbl.-Plas. Tech. & Eng., 22(2):177-188 (1984).
60.
Stokes, K. and K. Cobian. "Polyether Polyurethanes for Implantable Pacemaker Leads ," Biomaterials, 3:225 (October, 1982).
61.
Lyman, D. and J. Fazzio. "Synthetic Polymer Prosthesis Material," U.S. Patent 4,173,689 (November 6, 1979).
62.
DeCossart, L. and D. Annis. "An Assessment of Rigidly Controlled Technique for the Implantation in Dogs of a New Microfibrous, 3.8 mm I.D. Polyurethane Arterial Prosthesis," Proc. Second Ann. Scientific Session of the Academy of Surgical Res, Oct. 31-Nov. 1, 1986, Clemson, SC, p. 36 (1986).
63.
Pinchuk, L., J. Martin, et al. "Use of Small Filamentous Patches as a Means to Investigate Polyurethane Biodegradation," Transactions of the 13th Annual Meeting of the Society for Biomaterials, June 2-6, 1987, New York, p. 11 (1987).
64.
Levy, A., Vice President, Research and Technology, Ethicon, Inc., letter to customers who use Biomer segmented polyether urethane, stating that: "Devices composed of ultra fine fibers of Biomer in a very open construction may show a loss of mechanical strength within as little as 90 days in vivo residence."
65.
Ocumpaugh, D. and H. Lee. "Foreign Body Reactions to Plastic Implants," in Biomedical Polymers. A. Rembaum and M. Shen, eds. New York: Marcel Dekker Inc., pp. 101-119 (1971).
66.
White, R., L. Goldberg, et al. "Effect of Healing on Small Diameter Arterial Graft Compliance ," Biomat., Med. Dev., Artif., Org., 11(1):21-29 (1983).
67.
Autian, p. 199.
68.
Snow, J., H. Harasaki, et al. "Promising Results with a New Textured Surface Intrathoracic Variable Volume Device for LVAS," in Trans. Am. Soc Artif. Intern. Organs, Vol. XXVII, pp. 485-489 (1981).
69.
Wilkes, G., T. Dziemianowicz, et al. "Thermally Induced Time Dependence of Mechanical Properties in Biomedical Grade Polyurethanes," Jour. Biomed. Mater. Res. , 13:189-306 (1979).
70.
McMillin, C. "Physical Testing of Elastomers for Cardiovascular Applications," Artificial Organs, 7(1):78-91 (1983).
71.
Lilaonitkul, pp. 170-173.
72.
Dow Chemical USA, Technical Literature, Form No. 306-077-486, "Processing Guide," and Form No. 306-076-486, "Drying Thermoplastic Polyurethanes."
Mercor, Inc., Technical Literature, "Catalog of Biomaterials, Specialty Polymers and Reactive Intermediates."
75.
Olsen, D., D. Kessler, et al., University of Utah. "Fabrication, Implantation and Pathophysiology of the Total Artificial Heart in Calves for 6 Months," Proceedings, Circulatory Assist and Artificial Heart, USA-USSR Joint Symposium, pp. 31-56 (1979).
Personal communications with staff of Ethicon, Inc., Somerville, NJ.
78.
Poirier, p. 90.
79.
Helland, J. "Pacemaker Lead Complications, Clinical Significance and Patient Management," Medtronic News, pp. 8-14 (December, 1983).
80.
Stokes, K. "Transvenous Cardiac Pacing Leads-the Outlook," Medtronic News, pp. 14-16 (September, 1979).
81.
Stokes, K. "Polyurethane Lead Insulation, A Study in Biostability," Medtronic News, pp. 12-14 (June, 1981).
82.
Phua, S., J. Castillo, J. Anderson and A. Hiltner."Biodegradation of a Polyurethane, In Vitro," Jour. of Biomed. Mater. Res., 21:231-246 (1987).
83.
Paynter, R., H. Martz and R. Guidoin. "An X-Ray Photoelectron Spectroscopy Study of the External Surface of Explanted Microporous Polyurethane Vascular Prostheses."
84.
Smith, R., D. Williams and C. Oliver."The Biodegradation of Poly(ether urethanes),"Jour. of Biomed. Mater. Res., 21:1149-1166 (1987 ).
85.
Gladhill, K."In Vitro Studies of Biodegradation of Polyetherurethanes in Enzymatic Solutions," Masters Thesis, University of Washington, Seattle, WA (August 18, 1985).
